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ABSTRACT
Objective: Abnormal uterine bleeding is a common and troublesome problem in human immuno-
deficiency virus (HIV)-infected women. We sought to evaluate endometrial pathology among HIV-
infected women requiring hysterectomy to explore if endometritis may be common among these
patients.
Methods: We performed a retrospective analysis of uterine pathology specimens obtained from
HIV.infected and control patients requiring hysterectomy in two urban hospitals between 1988 and
1997 matched for age, surgical indication, and history of gonadotropin-releasing hormone (GnRH)
use. Cases were evaluated for the presence of plasma cells and assigned a grade between 0 and 3.
Results: Indications included cervical dysplasia (4), carcinoma in situ (2), abnormal uterine
bleeding (3), and adnexal mass (3). Some degree of abnormal uterine bleeding occurred in all cases.
Plasma cell endometritis was twice as common in HIVoinfected women compared to HIV-negative
specimens (11/11 versus 11/22) (P < 0.05). Plasma cell endometritis was also of a higher grade in
specimens from HIV-infected women than in controls (P 0.001).
Conclusion: Chronic endometritis was common and of a higher grade among HIV-infected
women requiring hysterectomy in our series. Diagnosis and treatment of endometritis should be
considered in HIV-infected women with uterine bleeding and/or tenderness. We speculate that
antiretroviral and/or antimicrobial treatment for endometritis may effectively treat endometritis and
eliminate the need for surgery in some HIV-infected women. We suggest that consideration and
treatment of endometritis in HIV-1 infected women being evaluated for possible hysterectomy has
the potential to reduce costs and morbidity for patients and providers who may be exposed during
surgical procedures. Infect. Dis. Obstet. Gynecol. 6:186-190, 1998. (C) 1998 Wiley-Liss, Inc.
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enstrual irregularities are common among hu-
man immunodeficiency virus (HIV)-infected
women. 1,z Studies report bleeding abnormalities in
approximately one third of HIV-infected women, z
As treatment and survival rates improve for HIV-
infected patients, care of the reproductive tract will
become increasingly important. It therefore be-
comes important to understand the underlying
mechanisms for abnormal menstrual bleeding in
HIV-infected patients. We hypothesize that HIV-
infected women suffer endometritis more fre-
quently then uninfected women and that endome-
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Patient (y) Indication use Patient (y) Indication
GnRH
use
32 Cervical dysplasia No
2 25 Cervical dysplasia No
3 41 Menorrhagia Yes
4 22 Cervical dysplasia No
5 25 Abnormal uterine Yes
bleeding, dysmenorrhea
6 35 Symptomatic fibroids Yes
7 36 Pelvic mass No
8 33 Pelvic mass No
9 33 Cervical dysplasia No
10 29 Cervical dysplasia No
II 30 Cervical dysplasia No
A 30 Cervical dysplasia
B 34 Cervical dysplasia
2A 25 Cervival dysplasia
2B 25 Cervical dysplasia
3A 41 Menorrhagia
3B 41 Menorrhagia
4A 29 Cervical dysplasia
4B 31 Cervical dysplasia
5A 29 Abnormal uterine bleeding, dysmenorrhea
5B 26 Abnormal uterine bleeding, dysmenorrhea
6A 35 Symptomatic fibroids
6B 37 Symptomatic fibroids
7A 33 Pelvic mass
7B 43 Pelvic mass
8A 40 Pelvic mass
8B 41 Pelvic mas
9A 38 Cervical dysplasia
9B 38 Cervical dysplasia
OA 26 Cervical dysplasia
lOB 28 Cervical dysplasia
A 32 Cervical dysplasia






















TABLE 2. Histopathology results for HIV-infected patients and controls
HIV-Infected
patients
Plasma Grade Plasma Grade




2 Yes 2 HSIL
3 Yes Chronic cervicitis/fibroids
4 Yes 2 HSIL/condyloma acuminatum
5 Yes Chronic cervicitis
6 Yes 2 Fibroids
7 Yes 3 TOA/fibroids
8 Yes Mucinous cystadenoma
9 Yes .HPV
I0 Yes 3 Adenomyosis
II Yes 2 HPV
A Yes LSIL
B Yes 2 LSIL
2A Yes HSIL, HPV
2B Yes LSIL
3A Yes Chronic cervicitis/fibroids
3B Yes Chronic cervicitis/fibroids
4A No 0 None
4B No 0 HPV
5A Yes None
5B No 0 Chronic cervicitis
6A Yes Fibroids
6B No 0 Adenomyosistfibroids
7A No 0 Chronic cervicitis, adenomyosis, endometriosis
7B No 0 TOA/fibroids
8A Yes 2 Mucinous cystadenoma
8B No 0 Mucinous cystadenoma
9A No 0 Adenomyosis
9B No 0 HPV
IOA Yes 0 None
lOB Yes None
A No .HPV
B No 0 None
aAbbreviations: LSIL, low-grade squamous-intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; HPV, human papillomavirus; TOA,
tuboovarian abscess.
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TABLE 3. Frequency of endometriosis based on





No. with No. with
chronic chronic
endometritis endometritis
Cervical dysplasia 4/4 6/I 2
Abnormal uterine bleeding 5/5 4/6
Adnexal mass 2/2 I/4
Total I/I (100%) 1/22 (50%)
*P < 0.05.




0 0/ (0%) / (50%)
4/i (36%) 9/22 (41%)
2 4/11 (36%) 2/22 (9%)
3 3/11 (27%) 0/22 (0%)
tritis may be a treatable cause of abnormal uterine
bleeding in HIV-infected women.
SUBJECTS AND METHODS
To evaluate this hypothesis, we retrospectively
compared the clinical history and hysterectomy
specimens of HIV-positive patients with HIV-
negative control women to determine 1) the fre-
quency of endometritis, 2) the severity of endome-
tritis, and 3) the specific symptoms associated with
histologic endometritis. We used databases in two
urban hospitals in Denver, Colorado, to identify 11
HIV-infected patients who underwent hysterec-
tomy between 1992 and 1997. Indications included
severe cervical dysplasia (4 cases), carcinoma in situ
(2 cases), abnormal uterine bleeding (3 cases), and
adnexal mass (2 cases). Each case was matched
with two controls for age (___1 year), past use of
gonadotropin-releasing hormone (GnRH)-agonist
therapy, and indication for surgery. Controls either
had a negative HIV test or were presumed to be
HIV-negative. A staff pathologist reviewed slides
from each case. All slides had identifying informa-
Fig. I. Histologic examination of grade-3 HIV-infected patient #7, demonstrating plasma cell infiltrate diagnostic of chronic
endometritis. Routine hematoxylin and eosin stain magnified at 40x.
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Fig. 2. Histologic examination of grade-3 HIV-infected patient #10, demonstrating plasma cell infiltrate diagnostic of chronic
endometritis. Routine hematoxylin and eosin stain magnified at 400x.
tion removed. A diagnosis of chronic endometritis
was based on presence of plasma cells within the
endometrium." Specimens were assigned a semi-
quantitative score based upon the total number of
plasma cells as follows: grade 0 for obscured plasma
cells, grade for 1-3, grade 2 for 4-9, and grade 3 for
10 per high power (400x) field.4 At least 10 fields
were examined for each specimen. After blinded
scoring, we compared plasma cell endometritis
among HIV-positive and HIV-negative women us-
ing chi-square tests for proportions and trend; alpha
was set at 0.05.
RESULTS
Tables and 2 show the presence of plasma cells,
grade of endometritis, and other pathologic diag-
noses. The HIV-infected patients demonstrated
significantly greater incidence of plasma cell endo-
metritis when compared with controls (11/11 versus
11/22; P < 0.05). The HIV-infected women were
significantly more likely to have grade I endome-
tritis (P 0.001, odds ratio 6), grade II endome-
tritis (odds ratio 20), and grade III endometritis
(odds ratio 48) when compared with controls
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(Tables 3 and 4). Figures and 2 show plasma cells
in the endometrium.
DISCUSSION
In this convenience sample of reproductive-aged
women who were treated with hysterectomy, we
found 1) more frequent chronic endometritis
among HIV-infected women and 2) more severe
chronic endometritis than in control women. A link
between endometritis and HIV infection has been
noted previously by Peuchmaur and colleagues.
These investigators used in situ hybridization in
endometrial samples obtained from an HIV-
infected woman and suggested that HIV is a direct
cause of endometritis in HIV-infected women.5
There may be other causes of endometritis among
HIV-infected women. HIV-induced impairment of
mucosal and systemic immune functions could re-
duce reproductive tract host defenses and increase
susceptibility to spread of lower reproductive tract
microorganisms into the endometrium. Addition-
ally, women with HIV may be at increased risk for
acquiring sexually transmitted infections or other
conditions, including bacterial vaginosis, that are
associated with endometritis.,6
This study is limited by its retrospective design
and the small number of cases. However, our find-
ings of an increased frequency and severity of en-
dometritis among HIV-infected women requiring
hysterectomy suggest that an active approach to
diagnosis and medical treatment of endometritis
should be considered prior to surgical management
of abnormal uterine bleeding in HIV-infected
women. Treatment with antiretroviral and indi-
cated antimicrobial agents aimed at eliminating en-
dometritis may obviate the necessity for surgical
treatment and reduce the risks and costs for both
patients and care providers. We presently provide
HIV-infected women with triple antiretroviral
treatment, including a protease inhibitor, prior to
elective gynecologic surgery.
Further studies are needed to determine 1) the
pathogenic mechanisms, 2) the microorganisms as-
sociated with endometritis in HIV-infected
women, and 3) optimal ways to treat endometritis
in these women.
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